首页> 外文期刊>JMIR diabetes. >Mobile Clinical Decision Support System for the Management of Diabetic Patients With Kidney Complications in UK Primary Care Settings: Mixed Methods Feasibility Study
【24h】

Mobile Clinical Decision Support System for the Management of Diabetic Patients With Kidney Complications in UK Primary Care Settings: Mixed Methods Feasibility Study

机译:移动临床决策支持系统,用于管理糖尿病患者肾脏并发症英国初级保健设施:混合方法可行性研究

获取原文

摘要

Background: Attempts to utilize eHealth in diabetes mellitus (DM) management have shown promising outcomes, mostly targeted at patients; however, few solutions have been designed for health care providers. Objective: The purpose of this study was to conduct a feasibility project developing and evaluating a mobile clinical decision support system (CDSS) tool exclusively for health care providers to manage chronic kidney disease (CKD) in patients with DM. Methods: The design process was based on the 3 key stages of the user-centered design framework. First, an exploratory qualitative study collected the experiences and views of DM specialist nurses regarding the use of mobile apps in clinical practice. Second, a CDSS tool was developed for the management of patients with DM and CKD. Finally, a randomized controlled trial examined the acceptability and impact of the tool. Results: We interviewed 15 DM specialist nurses. DM specialist nurses were not currently using eHealth solutions in their clinical practice, while most nurses were not even aware of existing medical apps. However, they appreciated the potential benefits that apps may bring to their clinical practice. Taking into consideration the needs and preferences of end users, a new mobile CDSS app, “Diabetes & CKD,” was developed based on guidelines. We recruited 39 junior foundation year 1 doctors (44% male) to evaluate the app. Of them, 44% (17/39) were allocated to the intervention group, and 56% (22/39) were allocated to the control group. There was no significant difference in scores (maximum score=13) assessing the management decisions between the app and paper-based version of the app’s algorithm (intervention group: mean 7.24 points, SD 2.46 points; control group: mean 7.39, SD 2.56; t 37 =–0.19, P =.85). However, 82% (14/17) of the participants were satisfied with using the app. Conclusions: The findings will guide the design of future CDSS apps for the management of DM, aiming to help health care providers with a personalized approach depending on patients’ comorbidities, specifically CKD, in accordance with guidelines.
机译:背景:在糖尿病中使用eHELTES(DM)管理的尝试显示了有希望的结果,主要针对患者;但是,很少有利于医疗保健提供者设计的解决方案。目的:本研究的目的是开展可行性项目开发和评估移动临床决策支持系统(CDSS)工具,专门用于医疗保健提供者来管理DM患者的慢性肾病(CKD)。方法:设计过程基于用户以用户为中心的设计框架的3个关键阶段。首先,探索性定性研究将DM专家护士在临床实践中使用移动应用的经验和观点。其次,开发了CDS工具,用于管理DM和CKD患者。最后,随机对照试验检查了工具的可接受性和影响。结果:我们采访了15名DM专家护士。 DM专家护士目前没有在临床实践中使用电子保健解决方案,而大多数护士甚至没有意识到现有的医疗应用程序。然而,他们赞赏应用程序可能带来临床实践的潜在利益。考虑到最终用户的需求和偏好,基于指南开发了新的移动CDSS应用程序“糖尿病和CKD”。我们招募了39年初级基金会1名医生(44%男性)来评估该应用程序。其中,将44%(17/39)分配给干预组,分配56%(22/39)向对照组分配。分数(最高分数= 13)没有显着差异(最高分数= 13)评估应用程序算法的应用程序和纸张版本之间的管理决策(干预组:平均7.24点,SD 2.46点;对照组:平均7.39,SD 2.56; t 37 = -0.19,p = .85)。然而,使用该应用程序满足82%(14/17)的参与者。结论:调查结果将指导未来CDS应用程序的设计,以便管理DM的管理,旨在根据指导方针,特别是CKD的患者的合并,帮助医疗保健提供者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号